Literature DB >> 9115025

The role of passive smoking in the development of bronchial obstruction during the first 2 years of life.

P Nafstad1, J Kongerud, G Botten, J A Hagen, J J Jaakkola.   

Abstract

We assessed the effect of exposure to environmental tobacco smoke on the risk of developing bronchial obstruction in a 2-year cohort study of 3,754 children born in Oslo, Norway, during a period of 15 months in 1992-1993. We collected questionnaire information on the child's health and environmental exposures at birth and when the child was age 6 months (follow up rate = 95%), 12 months (92%), 18 months (92%), and 24 months (81%). The outcome of interest was defined as two or more episodes of bronchial obstruction or one obstruction lasting more than 1 month, and it was verified by a specialist group evaluating data from questionnaires, clinical examinations, and health records. The risk of bronchial obstruction was increased in children exposed to environmental tobacco smoke (cumulative incidence = 0.109) compared with unexposed children (0.071), with an adjusted odds ratio of 1.6 [95% confidence interval (CI) = 1.3-2.1]. The effect was seen for maternal smoking alone (odds ratio = 1.6; 95% CI = 1.0-2.6), paternal smoking alone (odds ratio = 1.5; 95% CI = 1.1-2.2), and both parents smoking (odds ratio = 1.5; 95% CI = 1.0-2.2). There was no clear exposure-response pattern. The findings indicate that exposure to environmental tobacco smoke such as is experienced in Norwegian housing increases the risk of developing bronchial obstruction during the first 2 years of life.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9115025     DOI: 10.1097/00001648-199705000-00011

Source DB:  PubMed          Journal:  Epidemiology        ISSN: 1044-3983            Impact factor:   4.822


  10 in total

1.  Maternal smoking in pregnancy, fetal development, and childhood asthma.

Authors:  Jouni J K Jaakkola; Mika Gissler
Journal:  Am J Public Health       Date:  2004-01       Impact factor: 9.308

Review 2.  Health effects of passive smoking-10: Summary of effects of parental smoking on the respiratory health of children and implications for research.

Authors:  D G Cook; D P Strachan
Journal:  Thorax       Date:  1999-04       Impact factor: 9.139

3.  Interior surface materials in the home and the development of bronchial obstruction in young children in Oslo, Norway.

Authors:  J J Jaakkola; L Oie; P Nafstad; G Botten; S O Samuelsen; P Magnus
Journal:  Am J Public Health       Date:  1999-02       Impact factor: 9.308

4.  Indoor air quality and thermal comfort-results of a pilot study in elderly care centers in Portugal.

Authors:  Ana Mendes; Cristiana Pereira; Diana Mendes; Lívia Aguiar; Paula Neves; Susana Silva; Stuart Batterman; João Paulo Teixeira
Journal:  J Toxicol Environ Health A       Date:  2013

Review 5.  Environmental tobacco smoke (ETS) and respiratory health in children.

Authors:  Maria Cheraghi; Sundeep Salvi
Journal:  Eur J Pediatr       Date:  2009-03-20       Impact factor: 3.183

Review 6.  Perinatal gene-gene and gene-environment interactions on IgE production and asthma development.

Authors:  Jen-Chieh Chang; Lin Wang; Rong-Fu Chen; Chieh-An Liu
Journal:  Clin Dev Immunol       Date:  2012-02-28

7.  Asthma and COPD - The C/EBP Connection.

Authors:  Nicola Miglino; Michael Roth; Michael Tamm; Peter Borger
Journal:  Open Respir Med J       Date:  2012-04-20

8.  Environmental tobacco smoke, parental atopy, and childhood asthma.

Authors:  J J Jaakkola; P Nafstad; P Magnus
Journal:  Environ Health Perspect       Date:  2001-06       Impact factor: 9.031

9.  Maternal smoking during pregnancy increases the risk of recurrent wheezing during the first years of life (BAMSE).

Authors:  Eva Lannerö; Magnus Wickman; Goran Pershagen; Lennart Nordvall
Journal:  Respir Res       Date:  2006-01-05

Review 10.  The environment and asthma in U.S. inner cities.

Authors:  P A Eggleston; T J Buckley; P N Breysse; M Wills-Karp; S R Kleeberger; J J Jaakkola
Journal:  Environ Health Perspect       Date:  1999-06       Impact factor: 9.031

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.